CD8A and infection: A previous study showed that when a 28-day PMPA PEP regimen is used against SIVsmE660 infection in rhesus macaques, it can induce CD8+ cell-mediated control of viral replication and resistance to homologous challenge or heterologous challenge with SIVmac39 [18].